Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Hello

Deb does reference the approximate shares supporting the letter that was sent to the BoD. This does represent "major shareholders". I would like all shareholders, regardless of size, to become active in our effort.

I'm aware of your concerns but I view, as an example, Larbac's comments more constructive than Milestones. Before we exchange more opinions, will you and Milestone each respond to the two questions that I asked him earlier? Please, just a yes or no.

I look forward to you and Milestone joining the team to enhance shareholder value.

Stan

Share
New Message
Please login to post a reply